-
Automated Screening and Education Increases Urinary Incontinence Diagnoses
Implementing an automated urinary incontinence screening and educational program in primary care practices significantly increased awareness and treatment referrals in women with the condition, according to a recent study published in JAMA Internal Medicine.
-
Circadian Rhythm Causes Metabolic Dysfunction in Fat Cells
Northwestern Medicine scientists have discovered how disruptions in circadian rhythm impair metabolic function in fat cells, providing new insights into the molecular mechanisms that cause obesity and metabolic disease, according to a recent study published in Nature Metabolism.
-
AOA Medical Honor Society Inducts New Feinberg Members
Feinberg’s chapter of the Alpha Omega Alpha (AOA) medical honor society welcomed 41 new members during a ceremony on March 3, recognizing outstanding educational achievements and contributions to medicine.
-
Pioneer in Infectious Disease Genetics Wins 2026 Mechthild Esser Nemmers Prize
Jean-Laurent Casanova, MD, PhD, the Levy Family Professor at Rockefeller University, known for his discovery of the human genetic and immunological determinants of infectious diseases, is the recipient of the 2026 Mechthild Esser Nemmers Prize in Medical Science.
-
CAR T-cell Therapy Improves Survival in Relapsed or Refractory Lymphoma
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet.
-
Trashing Cancer’s ‘Undruggable’ Proteins
Northwestern scientists have developed polymers capable of grabbing proteins and directing them to the cell’s waste-disposal machinery, potentially triggering cancer cell death.
-
AI Model Predicts Language Development in Children with Hearing Loss
An advanced machine learning model predicted spoken language outcomes in children who received cochlear implants more accurately than traditional machine learning approaches, according to a recent Northwestern Medicine-led international multi-center study.
-
As Superagers Age, They Make at Least Twice as Many New Neurons as Their Peers
New research shows that the brains of “SuperAgers” continue to generate new neurons in the hippocampus at levels far higher than typical older adults, and even much younger individuals.
-
Living ‘Mini Brains’ Meet Next-Generation Bioelectronics
A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can eavesdrop on the hidden electrical dialogues unfolding inside miniature, lab-grown human brain-like tissues.
-
Nobel Laureate and Distinguished Scientist to Speak at 2026 Commencement
Robert J. Lefkowitz, MD, the Chancellor’s Distinguished Professor of Medicine and professor of Biochemistry and Chemistry at Duke University School of Medicine, will address graduates and their guests as the commencement speaker at Feinberg’s 2026 commencement.
-
Study Reveals Why Some Immune Disorders Trigger Severe Food Allergies — and Others Don’t
A new study has shed light on why patients with certain rare immune disorders develop severe, food‑triggered allergic reactions while others with similar diagnoses do not.
-
Inside the Feinberg Curriculum: The MD Program
A new video explores how Feinberg’s approach connects scientific discovery with clinical practice, preparing future physician leaders to advance patient-centered care and improve human health.
-
Targeting STING Pathway Triggers Cytotoxic and Immune Responses Against Meningioma
Northwestern Medicine scientists have discovered a potent immunotherapy approach for treating meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Communications.
-
HPV Cancer Vaccine Slows Tumor Growth, Extends Survival in Preclinical Model
Northwestern scientists have discovered that systematically changing the orientation and placement of a single cancer-targeting peptide can lead to drug formulations that supercharge the immune system’s ability to attack tumors.
-
Experimental Stroke Drug Slows Bleeding but Doesn’t Improve Recovery
A global clinical trial has found that recombinant factor VIIa, a drug designed to rapidly slow bleeding in the brain after a hemorrhagic stroke, does not improve long‑term recovery for patients, according to a study published in The Lancet
-
Advancing Preventive Care and Cardiovascular Risk Prediction Through Online Tools
Recently named to the Time100 Health 2026 list, Sadiya Khan, MD, is establishing herself as a leader in preventive cardiology and calling for younger people to think about their heart health earlier in life.
-
Targeting Cellular Mechanisms May Improve Immune Response in Chronic Infections
Northwestern Medicine scientists have identified cellular mechanisms that cause immune cells to differentiate and ultimately lose function during viral infection, findings that could improve therapeutic strategies for controlling chronic infection, according to a recent study.
-
Transitions in Dermatology Leadership: Dr. Amy S. Paller to Step Down as Chair
Amy S. Paller, MD, the chair and Walter J. Hamlin Professor of Dermatology, will be stepping down as chair after more than two decades of transformative and visionary leadership.
-
Common Anti-Seizure Drug Prevents Alzheimer’s Plaques from Forming
Northwestern University scientists have pinpointed when and where toxic proteins accumulate within the brains of Alzheimer’s patients — and discovered a decades-old Food and Drug Administration (FDA)-approved drug that can stop the accumulation process before it even begins, according to a recent study published in Science Translational Medicine.
-
Paralysis Treatment Heals Lab-Grown Human Spinal Cord Organoids
Using lab-grown human spinal cord organoids — miniature organs derived from stem cells — Northwestern scientists have modeled different types of spinal cord injuries and tested a promising new regenerative therapy.